(RTTNews) - Hoth Therapeutics, Inc. (HOTH), a biopharmaceutical firm, said on Wednesday that it has signed a Letter of Intent or LoI to merge with Algorithm Sciences, Inc., a company focused on ...
NEW YORK, April 26, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced it has signed a Letter of Intent to merge with Algorithm ...
Algorithm pipeline focused on Pulmonary Arterial Hypertension (PAH) a rare disease with a prevalence of ~100,000 patients in the US "Today's announcement is an exciting chapter for Hoth and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback